Bioactive Products
| A unique collection of 184 natural compounds used for Antibacterial research. | ||
| Catalog No: | Bb192 | Antibacterial Compound Library Screening Details |
| Size: | 1mg/well * 184 Compounds 2mg/well * 184 Compounds | |
| Cat. No. | Information |
| CFN93299 | o-Methoxycinnamaldehyde o-Methoxycinnamaldehyde from cinnamon has antibiotic activity, it is a competitive inhibitor against CYP1A2 while it was a mixed type inhibitor against CYP2E. |
| CFN90796 | 6,7,4'-Trihydroxyisoflavone 6,7,4'-Trihydroxyisoflavone, is a novel inhibitor of PKCα in suppressing solar UV-induced matrix metalloproteinase 1, which has antioxidant, and anti-cancer activities. 6,7,4'-trihydroxyisoflavone, suppresses adipogenesis in 3T3-L1 preadipocytes via ATP-competitive inhibition of PI3K. |
| CFN93180 | Methyl gallate Methyl Gallate is a plant polyphenol with antioxidant, anticancer, anti-bacterial, and anti-inflammatory activities.Methyl gallate is a potent and highly specific inhibitor of herpes simplex virus in vitro. Methyl gallate also has a dual cyclooxygenase-2/5-lipoxygenase inhibitory activity. Methyl gallate can inhibit the growth of oral pathogens and S. mutans biofilm formation, and may be used to prevent the formation of oral biofilms. |
| CFN93533 | Alliin Alliin has antiglycating potential , it offers protection against glucose or methyglyoxal induced glycation of superoxide dismutase, hence is expected to have therapeutic potential in the prevention of glycation-mediated diabetic complications. Alliin has anti-inflammatory activity, it protects against Lipopolysaccharides (LPS)-induced acute lung injury (ALI) by activating PPARγ, which subsequently inhibits LPS-induced NF-κB activation and inflammatory response; alliin has an inhibitory effect in osteoclasteogenesis with a dose-dependent manner via blocking the c-Fos-NFATc1 signaling pathway, it could be a potential therapeutic agent in the treatment of osteoporosis. Alliin and sabinene have detectable levels of antimicrobial activity. |
| CFN93532 | Desmethylbellidifolin Dimethylbellidifolin shows mutagenicity in Salmonella typhimurium TA100, TA98, TA97, and TA2637 by the preincubation method; it also exhibits at the dose of 200 ug/disk a significant inhibition of the growth of Staphylococcus aureus. Desmethylbellidifolin exhibits at the dose of 200 ug/disk a significant inhibition of the growth of Staphylococcus aureus. |
